Try it
Pharmacology · Toxicology: atropine endpoint in organophosphate poisoning
Sample itemA man with organophosphate poisoning has received 6 mg of atropine intravenously. His pupils are now dilated and heart rate is 130 per minute, but there are still crepitations throughout the chest and copious bronchial secretions. What is the correct decision?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Continue titrated atropine, since the chest secretions have not dried
In organophosphate poisoning the aim of atropine is to dry bronchial secretions and reverse bronchospasm, which cause death by respiratory failure. Pupil size and heart rate are unreliable guides because atropine and sympathetic activation also dilate pupils and speed the pulse. Atropine is titrated until the chest is clear, with a heart rate above 80 per minute and a systolic pressure above 80 mmHg.
Option by option
A. Stop atropine because of the tachycardia
Tachycardia can result from hypoxia or atropine and should not stop therapy while the chest is wet.
B. Switch to neostigmine
Neostigmine would worsen muscarinic toxicity by inhibiting cholinesterase further.
C. Continue titrated atropine, since the chest secretions have not dried (correct)
The chest endpoint has not been reached, so atropine must be continued.
D. Stop atropine because the pupils are dilated
Pupil size is an unreliable endpoint and persistent secretions still threaten respiration.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?